imiquimod has been researched along with Keloid in 30 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 18 (60.00) | 29.6817 |
| 2010's | 10 (33.33) | 24.3611 |
| 2020's | 2 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Aromataris, EC; Greenwood, JE; Klotz, T; Munn, Z | 1 |
| Benitez-Camacho, F; Fernández-Crehuet, JL; Fernández-Crehuet, P | 1 |
| Bayat, A; Ud-Din, S | 1 |
| Ferrándiz, L; Márquez García, A; Ojeda Vila, T; Ríos Martín, JJ | 1 |
| Arno, AI; Barret, JP; Gauglitz, GG; Jeschke, MG | 1 |
| Bagot, M; Battistella, M; Cavelier-Balloy, B; Duron, JB; Gorj, M; Hickman, G; Masson, V; May, P; Petit, A; Schneider, P; Vanhaecke, C; Vilmer, C | 1 |
| Enos, CW; Harvey, VM; Mantel, A; Trace, AP | 1 |
| Lee, NH; Roh, SG; Shin, JY; Yang, KM; Yun, SK | 1 |
| Mrowietz, U; Seifert, O | 1 |
| Cação, FM; Messina, MC; Tanaka, V | 1 |
| Berman, B; Harrison-Balestra, C; Perez, OA; Ramirez, C; Viera, M; Villa, A; Zell, D | 1 |
| Kelly, AP | 2 |
| Berman, B | 2 |
| Jones, N | 1 |
| Bergstrom, KG; Que, SK | 1 |
| Gauglitz, GG; Pavicic, T | 1 |
| Berman, B; Kaufman, J | 1 |
| Berman, B; Villa, A | 1 |
| Berman, B; Poochareon, VN | 1 |
| Barton, S; Berman, B; Hengge, U | 1 |
| Berman, B; Jacob, SE; Nassiri, M; Vincek, V | 1 |
| Busquets, AC; Martin-García, RF | 1 |
| Stashower, ME | 1 |
| Patel, PJ; Skinner, RB | 1 |
| Uysal, AC | 1 |
| Amjad, I; Chandawarkar, RY; Deckers, PJ; Piorkowski, J | 1 |
| Gupta, S; Khaitan, BK; Malhotra, AK; Sharma, VK | 1 |
| Chuangsuwanich, A; Gunjittisomram, S | 1 |
13 review(s) available for imiquimod and Keloid
| Article | Year |
|---|---|
Imiquimod to prevent keloid recurrence postexcision: A systematic review and meta-analysis.
Topics: Adjuvants, Immunologic; Administration, Cutaneous; Dermatologic Surgical Procedures; Humans; Imiquimod; Keloid; Postoperative Care; Recurrence; Secondary Prevention | 2020 |
Strategic management of keloid disease in ethnic skin: a structured approach supported by the emerging literature.
Topics: Aminoquinolines; Bleomycin; Cryosurgery; Dermatologic Agents; Electric Stimulation; Fluorouracil; Humans; Imiquimod; Injections, Intralesional; Keloid; Medical History Taking; Photochemotherapy; Physical Examination; Secondary Prevention; Silicone Gels; Steroids | 2013 |
Up-to-date approach to manage keloids and hypertrophic scars: a useful guide.
Topics: Adjuvants, Immunologic; Adrenal Cortex Hormones; Aminoquinolines; Anti-Inflammatory Agents; Antineoplastic Agents; Bleomycin; Botulinum Toxins, Type A; Cicatrix, Hypertrophic; Cryotherapy; Disease Management; Fluorouracil; Humans; Imiquimod; Injections, Intralesional; Interferons; Keloid; Lasers, Dye; Low-Level Light Therapy; Neuromuscular Agents; ortho-Aminobenzoates | 2014 |
Keloids and Hypertrophic Scars: A Spectrum of Clinical Challenges.
Topics: Adjuvants, Immunologic; Aminoquinolines; Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Antimetabolites; Bleomycin; Cell Proliferation; Cicatrix, Hypertrophic; Clinical Trials as Topic; Collagen; Combined Modality Therapy; Cryotherapy; Extracellular Matrix; Fibroblasts; Fluorouracil; Glucocorticoids; Humans; Imiquimod; Inflammation; Keloid; Laser Therapy; Wound Healing | 2016 |
Efficacy of 2 Representative Topical Agents to Prevent Keloid Recurrence After Surgical Excision.
Topics: Administration, Cutaneous; Aminoquinolines; Dermatologic Agents; Humans; Imiquimod; Keloid; Mitomycin; Recurrence; Treatment Outcome | 2017 |
Keloid scarring: bench and bedside.
Topics: Adult; Aminoquinolines; Cicatrix; Female; Genetic Predisposition to Disease; Humans; Imiquimod; Immunity, Cellular; Interleukin-10; Keloid; Polymorphism, Genetic; Pregnancy; Quality of Life; Signal Transduction; Smad Proteins; Transforming Growth Factor beta | 2009 |
Update on the management of keloids.
Topics: Adjuvants, Immunologic; Adrenal Cortex Hormones; Aminoquinolines; Black or African American; Cryosurgery; Humans; Imiquimod; Injections, Intralesional; Keloid; Laser Therapy | 2009 |
Biological agents for controlling excessive scarring.
Topics: Adjuvants, Immunologic; Aminoquinolines; Animals; Cicatrix, Hypertrophic; Clinical Trials as Topic; Etanercept; Humans; Imiquimod; Immunoglobulin G; Immunologic Factors; Interferon alpha-2; Interferon-alpha; Keloid; Receptors, Tumor Necrosis Factor; Recombinant Proteins; Tumor Necrosis Factor-alpha | 2010 |
Scar tissue.
Topics: Adjuvants, Immunologic; Aminoquinolines; Cicatrix, Hypertrophic; Dermabrasion; Esthetics; Glucocorticoids; Humans; Imiquimod; Intercellular Signaling Peptides and Proteins; Keloid; Laser Therapy; Plastic Surgery Procedures; Radiotherapy; Silicone Gels; Stem Cell Transplantation; Tissue Expansion; Triamcinolone; Vitamin E; Vitamins | 2010 |
Imiquimod 5% cream for keloid management.
Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Chemotherapy, Adjuvant; Humans; Imiquimod; Keloid; Secondary Prevention; Surgical Procedures, Operative | 2003 |
New therapies for the management of keloids.
Topics: Adrenal Cortex Hormones; Aminoquinolines; Chemotherapy, Adjuvant; Humans; Imiquimod; Immunosuppressive Agents; Interferon alpha-2; Interferon Inducers; Interferon-alpha; Keloid; Laser Therapy; Recombinant Proteins; Tacrolimus | 2003 |
Successful management of viral infections and other dermatoses with imiquimod 5% cream.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Aged; Aged, 80 and over; Aminoquinolines; Carcinoma in Situ; Child; Condylomata Acuminata; Female; Humans; Imiquimod; Keloid; Male; Middle Aged; Molluscum Contagiosum; Skin Diseases; Virus Diseases; Vulvar Neoplasms | 2003 |
Medical and surgical therapies for keloids.
Topics: Adrenal Cortex Hormones; Aminoquinolines; Fluorouracil; Humans; Imiquimod; Injections, Subcutaneous; Interferons; Keloid | 2004 |
3 trial(s) available for imiquimod and Keloid
| Article | Year |
|---|---|
Treatment of keloid scars post-shave excision with imiquimod 5% cream: A prospective, double-blind, placebo-controlled pilot study.
Topics: Adjuvants, Immunologic; Administration, Topical; Adolescent; Adult; Aged; Aminoquinolines; Double-Blind Method; Drug Administration Schedule; Humans; Imiquimod; Keloid; Middle Aged; Pilot Projects; Postoperative Complications; Prospective Studies; Recurrence; Treatment Outcome | 2009 |
Successful treatment of earlobe keloids with imiquimod after tangential shave excision.
Topics: Administration, Topical; Adolescent; Adult; Aminoquinolines; Antineoplastic Agents; Chemotherapy, Adjuvant; Ear Deformities, Acquired; Female; Follow-Up Studies; Humans; Imiquimod; Keloid; Pilot Projects; Secondary Prevention; Treatment Outcome | 2006 |
The efficacy of 5% imiquimod cream in the prevention of recurrence of excised keloids.
Topics: Adjuvants, Immunologic; Administration, Topical; Adolescent; Adult; Aminoquinolines; Child; Female; Humans; Imiquimod; Interferon Inducers; Keloid; Male; Middle Aged; Postoperative Care; Prospective Studies; Secondary Prevention; Time Factors; Wound Healing | 2007 |
14 other study(ies) available for imiquimod and Keloid
| Article | Year |
|---|---|
Successful cosmetic outcome of earlobe keloid after surgical excision and topical imiquimod 5.
Topics: Aminoquinolines; Ear Diseases; Esthetics; Humans; Imiquimod; Keloid | 2020 |
Hypertrophic and keloid scars after the application of 5% imiquimod cream: a report of 2 cases.
Topics: Adult; Aged; Aminoquinolines; Cicatrix, Hypertrophic; Dosage Forms; Drug Eruptions; Female; Humans; Imiquimod; Keloid; Male | 2014 |
Plantar keloids: diagnostic and therapeutic issues in six patients.
Topics: Adjuvants, Immunologic; Adult; Aminoquinolines; Biopsy; Colchicine; Dermatologic Surgical Procedures; Drug Administration Routes; Female; Follow-Up Studies; Foot Dermatoses; Foot Orthoses; Glucocorticoids; Gout Suppressants; Humans; Imiquimod; Keloid; Keratolytic Agents; Magnetic Resonance Imaging; Male; Recurrence; Retrospective Studies; Treatment Outcome; Triamcinolone | 2015 |
Failure of imiquimod 5% cream to prevent recurrence of surgically excised trunk keloids.
Topics: Adjuvants, Immunologic; Administration, Topical; Adult; Aminoquinolines; Emollients; Female; Humans; Imiquimod; Keloid; Male; Middle Aged; Secondary Prevention; Treatment Outcome; Young Adult | 2009 |
What's new in treatment of keloids? New applications for common therapies, new treatments to come.
Topics: Adjuvants, Immunologic; Aminoquinolines; Fluorouracil; Humans; Imiquimod; Immunosuppressive Agents; Keloid; Secondary Prevention; Treatment Outcome | 2011 |
[Emerging strategies for the prevention and therapy of excessive scars].
Topics: Adjuvants, Immunologic; Adrenal Cortex Hormones; Aminoquinolines; Botulinum Toxins, Type A; Cicatrix, Hypertrophic; Cryosurgery; Esthetics; Fluorouracil; Humans; Imiquimod; Injections, Intralesional; Keloid; Laser Therapy; Plastic Surgery Procedures; Risk Factors | 2012 |
Pilot study of the effect of postoperative imiquimod 5% cream on the recurrence rate of excised keloids.
Topics: Adjuvants, Immunologic; Administration, Topical; Adult; Aminoquinolines; Ear, External; Female; Follow-Up Studies; Humans; Imiquimod; Interferon Inducers; Keloid; Male; Middle Aged; Pilot Projects; Postoperative Care; Recurrence; Time Factors | 2002 |
Topical application of imiquimod 5% cream to keloids alters expression genes associated with apoptosis.
Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Apoptosis; Arabidopsis Proteins; Caspase 3; Caspase 6; Caspase 8; Caspases; Drug Administration Schedule; Fatty Acid Desaturases; Gene Expression; Humans; Imiquimod; Keloid; Lymphotoxin-alpha | 2003 |
Postsurgical use of imiquimod 5% cream in the prevention of earlobe keloid recurrences: results of an open-label, pilot study.
Topics: Adolescent; Adult; Aminoquinolines; Antineoplastic Agents; Ear Diseases; Ear, External; Female; Humans; Imiquimod; Keloid; Male; Pilot Projects; Recurrence; Treatment Outcome | 2005 |
Experience with keloids after excision and application of 5% imiquimod cream.
Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Drug Administration Schedule; Ear Diseases; Ear, External; Humans; Imiquimod; Keloid; Secondary Prevention | 2006 |
Topical interferon-alpha2b and keloid treatment: a place for pretreatment?
Topics: Adjuvants, Immunologic; Administration, Topical; Adult; Aminoquinolines; Combined Modality Therapy; Ear, External; Female; Humans; Imiquimod; Interferon Inducers; Keloid; Male; Pilot Projects | 2006 |
Combination therapy of a large, recurrent keloid.
Topics: Adjuvants, Immunologic; Adult; Aminoquinolines; Cicatrix, Hypertrophic; Combined Modality Therapy; Graft Survival; Humans; Imiquimod; Keloid; Male; Neck; Occlusive Dressings; Recurrence; Skin Transplantation | 2007 |
Imiquimod 5% cream for the prevention of recurrence after excision of presternal keloids.
Topics: Administration, Topical; Adult; Aminoquinolines; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Administration Schedule; Follow-Up Studies; Humans; Imiquimod; Keloid; Male; Ointments; Secondary Prevention; Severity of Illness Index; Sternum; Treatment Outcome | 2007 |
Imiquimod: a new immune response modifier for the treatment of external genital warts and other diseases in dermatology.
Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Follow-Up Studies; Humans; Imiquimod; Immunity, Innate; Keloid; Molluscum Contagiosum; Molluscum contagiosum virus; Papillomaviridae; Papillomavirus Infections; Pilot Projects; Recurrence; Warts | 2002 |